Invesco India Nifty India Defence Index Fund – NFO

Invesco India Nifty India Defence Index Fund – NFO

India’s defence sector has been undergoing significant changes, with increasing focus on domestic manufacturing, defence modernisation, indigenous technology, exports and participation from private companies and startups. Invesco Mutual Fund has introduced the Invesco India Nifty India Defence Index Fund to provide investors with focused exposure to companies forming part of the Nifty India Defence Index. What is this fund? This is an open-ended index fund that follows a passive investment strategy. The scheme will invest in the companies that are constituents of the Nifty India Defence Index, broadly in the…

Read More

JioBlackRock Balanced Advantage Fund NFO – Simple Investor Guide

JioBlackRock Balanced Advantage Fund NFO – Simple Investor Guide

JioBlackRock Mutual Fund has launched the JioBlackRock Balanced Advantage Fund, a hybrid mutual fund designed to invest in both equity and debt and dynamically change its allocation as market conditions change. The NFO is open from 11 September 2026 to 25 September 2026. The scheme is an open-ended Dynamic Asset Allocation / Balanced Advantage Fund and is benchmarked against the Nifty 50 Hybrid Composite Debt 50:50 Index (TRI). 🤔 Why does a Balanced Advantage Fund matter? One of the biggest difficulties for an investor is deciding: “When should I invest…

Read More

Invesco India Pharma and Healthcare Fund (NFO): An Opportunity to Participate in India’s Growing Healthcare Ecosystem

Invesco India Pharma and Healthcare Fund (NFO): An Opportunity to Participate in India’s Growing Healthcare Ecosystem

India’s healthcare sector is undergoing a significant transformation. The country’s traditional strength in pharmaceuticals is now being complemented by growth across hospitals, diagnostics, biotechnology, medical devices, health insurance and digital healthcare infrastructure. This expanding ecosystem presents a broad range of opportunities across the healthcare value chain. The Invesco India Pharma and Healthcare Fund is an open-ended equity scheme designed to invest predominantly in companies operating in the pharmaceuticals, healthcare and allied sectors. 📅 Key Dates Particular Details NFO Open 18 Aug 2026 NFO Close 01 Sep 2026 NFO Re-Open 11…

Read More

The Wealth Company Mid Cap Fund NFO : Should You Invest in India’s Next Growth Leaders?

The Wealth Company Mid Cap Fund NFO

The Wealth Company Mid Cap Fund NFO: Should You Invest in India’s Next Growth Leaders? The Indian economy continues to create opportunities for businesses beyond the large-cap universe. Many of tomorrow’s market leaders are currently mid-sized companies, making mid-cap investing an attractive option for long-term wealth creation. To tap into this opportunity, The Wealth Company Mutual Fund has launched The Wealth Company Mid Cap Fund, an open-ended equity scheme predominantly investing in mid-cap companies. The NFO opened on 15 July 2026 and will close on 29 July 2026. What is…

Read More

“The Wealth Company’s New NFO – Large & Mid Cap Fund NFO Guide – June 2026”

The Wealth Company Large & Mid Cap Fund NFO

The Wealth Company Large & Mid Cap Fund NFO opens on May 21, 2026 and closes on June 4, 2026. It is an equity mutual fund that invests in both large-cap (stable, established companies) and mid-cap (fast-growing, emerging businesses) stocks, offering a blend of growth and stability. However, it carries a Very High Risk rating, meaning investors should be prepared for significant ups and downs in returns. 📅 Key Dates Particular Details NFO Open 21 May 2026 NFO Close 04 June 2026 NFO Re-Open 12 February 2026 Scheme TYPE An…

Read More